Has Cencora (COR) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. Cencora is a member of our Medical group, which includes 1002 ...

Has Cencora (COR) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

Shares of Cencora Inc. COR rallied 1.24% to $285.90 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 and ...

Morgan Stanley analyst Erin Wright raised the firm’s price target on Cencora (COR) to $288 from $263 and keeps an Equal Weight rating on the shares. While policy will be “front and center ...

CONSHOHOCKEN, PA — Cencora has introduced Accelerate Pharmacy Solutions, a comprehensive portfolio aimed at helping hospitals and health systems enhance operations and improve financial performance.

$60,000 of CENCORA INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "IRA implementation. Drug Shortages ...

Cencora COR has outperformed the market over the past 5 years by 12.25% on an annualized basis producing an average annual return of 25.82%. Currently, Cencora has a market capitalization of $55. ...

Citi analyst Daniel Grosslight maintained a Buy rating on Cencora (COR – Research Report) today and set a price target of $330.00. The company’s shares closed yesterday at $284.44. Discover ...

Shares of Cencora Inc. COR slid 1.38% to $274.56 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.23% to 5,062.25 and Dow ...